Can Lisinopril Be Taken Twice a Day?

Lisinopril is approved and almost universally prescribed as a once-daily medication, but some doctors do prescribe it twice a day in specific situations. The drug’s pharmacokinetics sit in an interesting gray zone: its effective half-life is shorter than its labeled duration suggests, and a small body of clinical research has explored whether splitting the daily dose into two servings improves blood pressure control. The answer depends on why you’re taking it, how your kidneys are functioning, and what your blood pressure looks like in the last few hours before your next dose.

Why Once a Day Is the Standard

Lisinopril’s prescribing information calls for one dose every 24 hours, and that recommendation rests on how the drug behaves in the body. When researchers measured lisinopril levels in healthy volunteers, they found the terminal half-life was long, roughly 40 hours. That number sounds like the drug should last nearly two full days. But the terminal half-life is misleading here. The accumulation half-life, which better predicts how drug levels build up with repeated daily dosing, averages about 12.6 hours. Steady-state blood levels are reached after just two daily doses given every 24 hours.¹

That 12.6-hour effective half-life matters. It means that by hour 20 or so after a dose, the drug’s blood-pressure-lowering effect is waning compared to its peak. For many people, the residual effect at 24 hours is still strong enough to keep blood pressure controlled. But not for everyone, and this gap between peak and trough action is exactly where the twice-daily question becomes relevant.

Compared to older ACE inhibitors like captopril, which has a short duration and genuinely requires two or three doses per day, lisinopril and enalapril have a longer duration of action that typically justifies once-daily dosing.² That convenience was a selling point when lisinopril came to market and remains a practical advantage.

Measuring How Well One Dose Covers 24 Hours

Researchers use a metric called the trough-to-peak ratio to judge whether a once-daily drug is still working near the end of its dosing interval. A ratio of 1.0 would mean the drug works just as well at hour 24 as it does at its peak. The FDA has historically considered a ratio above 0.50 acceptable for once-daily blood pressure drugs.

Studies measuring lisinopril’s trough-to-peak ratio have generally found it in the acceptable range, though with some caveats. In one trial comparing lisinopril with captopril, once-daily lisinopril at 20 mg achieved a trough-to-peak ratio of about 0.75 for blood pressure reduction, which is considered favorable.³ Another comparison with telmisartan found lisinopril’s ratio at 0.74 for systolic pressure and 0.64 for diastolic, with both drugs providing smooth effects through a full 24-hour period.⁴

But these are averages across groups of patients, and averages can hide a lot of individual variation. One carefully designed study illustrated this starkly. The conventional trough-to-peak ratio for lisinopril was 0.72 for systolic pressure when calculated the usual way. But when the researchers accounted for how much individuals varied, the median ratio dropped to 0.34, and some patients had ratios that were actually negative, meaning their blood pressure was higher at trough than it would have been without the drug’s peak effect pulling the average up.⁵ In plain terms, some people on once-daily lisinopril are barely getting any benefit in the last several hours before their next dose. Those are the patients for whom twice-daily dosing makes the most intuitive sense.

What the Research Says About Twice-Daily Dosing

Surprisingly little formal research has directly compared once-daily with twice-daily lisinopril. The studies that exist point in somewhat different directions.

A crossover trial enrolled patients already on stable once-daily lisinopril and switched them to the same total daily dose split into two servings. The results were striking: twice-daily dosing was associated with a systolic blood pressure reduction roughly 10 mmHg greater than once-daily dosing using the same total amount of drug. The diastolic reduction was about 4 mmHg greater, though that difference was not statistically robust.⁶ That’s a clinically meaningful difference in systolic pressure from simply splitting the same dose.

However, a larger observational study using real-world pharmacy and medical records told a different story. When researchers compared patients prescribed twice-daily lisinopril to those on once-daily lisinopril in routine clinical practice, they found no differences in follow-up blood pressure readings between the two groups. The adjusted analysis did not support improved effectiveness or safety with twice-daily dosing.⁷

These two findings aren’t necessarily contradictory. The crossover trial was controlled, meaning the same patients took both regimens, eliminating variation between individuals. The real-world study captured what happens in everyday practice, where patients prescribed twice-daily dosing may miss that second dose, may have been switched to twice daily because their blood pressure was harder to control in the first place, or may differ from once-daily patients in dozens of unmeasured ways. The crossover trial’s result is more informative about the drug’s pharmacology, while the observational study reflects what actually happens when doctors write a twice-daily prescription and send patients home with it.

When Doctors Actually Prescribe It Twice Daily

Most prescribers stick with once-daily lisinopril because it works well enough for the majority of patients and because simplicity matters. But there are recognizable clinical scenarios where splitting the dose comes up.

End-of-dose breakthrough: If your blood pressure is well controlled in the afternoon but creeps up in the early morning hours before your next dose, your doctor may suspect that the drug isn’t lasting a full 24 hours for you personally. Splitting the dose can smooth out coverage.
Maximized once-daily dose: When a patient is already on the maximum recommended once-daily dose (typically 40 mg for hypertension) and still isn’t at target, some clinicians will split the dose rather than add a second drug, hoping the pharmacokinetic advantage closes the gap.
Proteinuria reduction: In kidney disease, ACE inhibitors are used partly to reduce protein in the urine. Some evidence suggests that higher doses achieve greater reductions in urinary albumin excretion. One crossover trial in type 1 diabetes found that 40 mg daily reduced urinary albumin about 23% more than the standard 20 mg dose, though going higher to 60 mg offered no further benefit.⁸ When clinicians push doses higher for kidney protection, splitting can help manage side effects like dizziness.

In heart failure, lisinopril is also used once daily. The landmark ATLAS trial tested high-dose lisinopril (32.5 to 35 mg once daily) against low-dose (2.5 to 5 mg once daily) and found clinically important advantages for the higher dose.⁹ In heart failure patients, the drug’s peak effects occur about six to eight hours after a dose and persist for 12 to 24 hours. That window is wide enough for once-daily dosing in most cases, but some heart failure specialists will split the dose if a patient is symptomatic late in the dosing interval.

How Kidney Function Changes the Drug’s Behavior

Lisinopril is unusual among ACE inhibitors because it is not processed by the liver at all. It is absorbed from the gut and eliminated entirely through the kidneys, unchanged. That means kidney function has a direct and powerful influence on how long the drug stays in your system.

In patients with impaired kidney function, peak blood levels of lisinopril are higher, the decline in concentration is slower, and the time to reach peak concentration is extended. The effective half-life roughly doubles in mild kidney impairment and triples in severe impairment compared to people with normal kidneys.¹⁰ Population-level analyses confirm that creatinine levels, age, weight, and heart failure status all significantly affect how quickly the body clears lisinopril.¹¹

This has two practical implications for the twice-daily question. First, if you have significant kidney disease, the drug already lasts longer in your body, so the end-of-dose problem that motivates twice-daily dosing is less likely to apply to you. Second, splitting the same total dose into two servings could cause accumulation problems in someone whose kidneys aren’t clearing the drug efficiently, leading to low blood pressure, elevated potassium, or worsening kidney function. In clinical practice, patients with reduced kidney function typically start on lower once-daily doses, sometimes as low as 2.5 or 5 mg.¹²

The Adherence Trade-Off

One of the strongest practical arguments against twice-daily dosing is that people are measurably worse at taking medications when the schedule is more complex. A meta-analysis of studies on antihypertensive adherence found that once-daily dosing averaged about 93% adherence, while twice-daily dosing averaged about 87%.¹³ That gap may sound small, but over months and years it compounds. A missed evening dose means hours of uncontrolled blood pressure, and the people most likely to miss doses are often the ones at highest cardiovascular risk.

Research on chronic medications more broadly echoes this pattern. In a study of patients on blood-thinning drugs, those on once-daily regimens were roughly 60% more likely to be adherent at 12 months than those on twice-daily regimens.¹⁴ The finding isn’t unique to any drug class. Adding a second daily dose introduces a second opportunity to forget, and habits around an evening pill are harder to form than a morning routine anchored to breakfast or other medications.

This is likely part of why the real-world observational study found no benefit from twice-daily lisinopril even though the controlled crossover trial did. In a research setting where every dose is accounted for, splitting the dose helps. In real life, the adherence penalty may erase the pharmacological gain.

Morning Versus Evening Dosing

A related question many patients have is whether taking lisinopril at bedtime instead of in the morning could accomplish some of the same goals as twice-daily dosing, particularly for people whose blood pressure doesn’t dip normally during sleep (a pattern called non-dipping). Clinical studies on ACE inhibitors have shown that evening dosing often produces a more pronounced effect on nighttime blood pressure compared to morning dosing.¹⁵

For years, a Spanish research group reported that bedtime dosing of blood pressure medications dramatically reduced cardiovascular events, which generated a lot of excitement around the idea of chronotherapy. But two large independent trials have failed to confirm that benefit. The UK-based TIME study, which randomized over 21,000 adults, found that cardiovascular event rates were essentially identical whether patients took their blood pressure medications in the morning or evening.¹⁶ The Canadian BedMed trial, with a median follow-up of 4.6 years, reached the same conclusion: no difference in cardiovascular events between bedtime and morning dosing.¹⁷

An updated systematic review and meta-analysis put the full picture together. The overall analysis found no statistically significant reduction in cardiovascular risk with bedtime dosing. When results were broken out by research group, the dramatic benefit seen in the Spanish group’s studies was not replicated by any other investigators, whose pooled data showed essentially no effect at all.¹⁸ The current consensus is that you can take lisinopril at whatever time works best for your schedule without worrying that you’re missing a cardiovascular benefit. If you have a documented non-dipping pattern, your doctor may still suggest bedtime dosing to target nighttime pressure specifically, but that’s a selective recommendation, not a general one.

Practical Concerns With Splitting Tablets

If your doctor does prescribe twice-daily lisinopril, the logistics of actually splitting tablets matter. Some patients are given a higher-strength tablet and asked to split it to create two doses, either to save money or because the specific half-dose strength isn’t commercially available.

Research on lisinopril tablet splitting found that using a tablet splitter produces reasonably consistent halves, but splitting by hand is a different story. In one study, 37 out of 40 hand-split tablet halves varied by more than 10% from the target weight, which directly affected the drug content of each half. The pharmacopoeia requirements for disintegration and friability were still met, but the dose accuracy was poor enough that researchers flagged it as a potential clinical safety issue, especially for drugs where precise dosing matters.¹⁹ Lisinopril has a fairly wide therapeutic window, so a 10% variation in dose is unlikely to cause harm in most patients. But if you’re splitting tablets, use a proper tablet splitter rather than your fingers or a knife.

Children and Twice-Daily ACE Inhibitors

Pediatric dosing of lisinopril follows a somewhat different logic. Children metabolize drugs differently than adults, and dosing is weight-based rather than fixed. In a pharmacokinetic study of children aged six months to 15 years, younger children received a suspension formulation at 0.15 mg per kilogram per day, while older children received tablets adjusted by body weight.²⁰ Pediatric prescribing of lisinopril is generally once daily, consistent with adult practice, though pediatric nephrologists sometimes adjust frequency based on individual response and the indication being treated. The key difference in children is that kidney function relative to body size changes as children grow, so what works at age 4 may need adjustment at age 10.

Higher Doses Versus More Frequent Doses

One of the decisions your doctor faces when once-daily lisinopril isn’t controlling your blood pressure is whether to increase the dose, split the existing dose, or add a different drug entirely. These aren’t equivalent choices.

Increasing the once-daily dose is the simplest approach and maintains the adherence advantage of a single daily pill. For kidney protection in diabetic nephropathy, increasing from 20 mg to 40 mg once daily produced meaningfully greater reductions in urinary albumin excretion.⁸ Similarly, a study in diabetic nephropathy patients found that high-dose lisinopril produced significantly lower microalbuminuria levels at three months compared to low-dose lisinopril, without significantly different creatinine or potassium levels between the groups.²¹

Splitting the dose makes pharmacological sense mainly when the problem is end-of-dose blood pressure escape rather than insufficient peak effect. If your blood pressure is well controlled for the first 16 hours but rises in the last 8, splitting addresses the specific problem. If your blood pressure is inadequately controlled even at peak, a higher total dose or a second drug is more logical. Most guidelines favor adding a second antihypertensive from a different class over splitting or escalating a single drug to very high doses, because combining mechanisms tends to produce better blood pressure reduction with fewer dose-dependent side effects.

The distinction matters because patients sometimes assume that “more frequent” and “higher dose” are interchangeable. They’re not. Taking 10 mg twice daily delivers the same total drug over 24 hours as 20 mg once daily, but with different peak and trough levels. Taking 20 mg twice daily doubles your total daily dose, which is a substantially different intervention with a different risk profile for side effects like low blood pressure, dizziness, elevated potassium, and reduced kidney function. Any change to how often you take lisinopril should come from your prescriber, not from self-adjustment.